TENAX THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tenax Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q2 2024.
  • Tenax Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $9.19K, a 0.69% increase year-over-year.
  • Tenax Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $24.6K, a 46.3% increase year-over-year.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2023 was $24K, a 439% increase from 2022.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2022 was $4.44K, a 368% increase from 2021.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2021 was $949.000, a 41.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $24.6K $9.19K +$63.00 +0.69% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $24.6K $7.96K +$613 +8.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $24K $2.15K +$2.15K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $21.8K $5.34K +$4.97K +1335% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $16.8K $9.13K +$7.64K +515% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $9.21K $7.35K +$4.76K +184% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $4.44K $0 -$1.23K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $5.67K $372 +$372 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $5.3K $1.48K +$1.15K +342% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.15K $2.59K +$3.2K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $949 $1.23K -$1.42K -53.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.37K $0 +$610 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.76K $336 +$742 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.01K -$613 -$613 Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $1.63K $2.64K Oct 1, 2020 Dec 31, 2020 10-K/A 2021-04-16
Q3 2020 -$610 -$610 Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q2 2020 -$406 -$406 Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q4 2016 $0 $0 Oct 1, 2016 Dec 31, 2016 10-K 2017-03-16
Q3 2016 $0 -$571 -100% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $0 -$1.4K -100% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $0 -$1.82K -100% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q3 2015 $4.76K $571 +$512 +868% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $4.25K $1.4K -$44.9K -97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $49.1K $1.82K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $968 -$69K -98.6% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-17
Q3 2014 $59.00 -$1.42M -100% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-10
Q2 2014 $46.3K -$610K -92.9% May 1, 2014 Jul 31, 2014 10-Q 2015-09-09
Q4 2013 $70K -$752K -91.5% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $1.42M +$549K +63.3% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 $656K -$1.27M May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q4 2012 $822K -$4.52M Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $868K -$4.24K -0.49% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-17
Q2 2012 $1.93M* +$1.49M May 1, 2012 Jul 31, 2012 10-Q 2013-09-17
Q4 2011 $6.51M $5.34M* +$5.39M Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $1.13M $872K +$866K +16095% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 $263K $436K +$435K +36036% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q1 2011 -$172K -$135K Feb 1, 2011 Apr 30, 2011 10-K 2012-07-25
Q4 2010 -$43.1K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-15
Q3 2010 $5.38K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 $1.21K May 1, 2010 Jul 31, 2010 10-Q 2011-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.